RNF213 and Moyamoya Disease in Children
Official title: RNF213: Molecular Functions and Moyamoya Disease
Funded at University of Texas Hlth Sci Ctr Houston · NIH-11356605 · Data updated 2026-11-12
A study in young children will explore how the RNF213 gene affects blood vessel cells and contributes to Moyamoya disease, with the aim of finding new ways to prevent or treat strokes.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | June 9, 2026 |
| Project end | May 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $429,000 |
| NIH project number | 1R21NS149248-01 |
| Project ID | NIH-11356605 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children and young infants with or at risk for Moyamoya disease, especially those with RNF213-related variants.
✕Less likely to help
Children without Moyamoya or without RNF213 variants may not benefit from this specific genetic-focused approach.
What this research studies
This project focuses on Moyamoya disease, a condition where brain arteries narrow and can cause stroke in kids. Researchers will look at how a specific RNF213 variant seen in Asian families changes cell behavior, especially smooth muscle cells, and whether this leads to blocked vessels. They will connect laboratory findings to how the disease develops in very young patients and test strategies that may boost cell energy production to restore normal differentiation. The work builds on earlier findings that altering mitochondrial function can help prevent lesion formation in mouse models. The study combines genetic analysis with cell and animal experiments to map the steps from RNF213 mutation to vessel occlusion in early life.
Why it matters
Potential benefit: Understanding RNF213’s role could guide targeted therapies to prevent or slow Moyamoya in children.
How similar studies have gone: Prior work suggests RNF213 variants contribute to disease and mitochondrial pathways can influence vessel cell behavior, indicating a promising but continuing line of research.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Milewicz, Dianna M — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Milewicz, Dianna M
Related research
Other NIH-funded projects on the same topics.
-
Personalized vascular and metabolic signs after revascularization in moyamoya disease
A multi-site study will look at brain imaging and blood/CSF signals in adults with moyamoya disease to understand which biomarkers relate to stroke risk and how patients respond to treatment.
-
Understanding how blood flow and brain health relate to treatment in moyamoya disease
This study is looking at how blood flow and certain markers can help us understand the risk of strokes in people with moyamoya disease, so we can better identify who might benefit from surgery to improve their condition.
-
Investigating the role of a gene in the development of Moyamoya disease
This study is looking at how a specific gene called SETD5 affects Moyamoya disease, which causes blood vessels in the brain to narrow and can lead to strokes, especially in kids, with the goal of finding new ways to help improve treatment for patients.
-
Risk prediction for stroke and cognitive decline in Moyamoya disease and Moyamoya syndrome
A large multicenter study tests whether combining clinical data, imaging, lab and genetic information can predict who will have stroke or cognitive decline among people with Moyamoya.
-
5T MRI and Metabolomics to Predict Hemorrhage Risk in Moyamoya Disease
This study tests whether advanced 5T MRI imaging and metabolomics can help predict which moyamoya patients are at higher risk of intracranial hemorrhage.
-
XR-assisted CT-guided localization for EC-IC bypass in Moyamoya and chronic cerebral ischemia
The study tests whether a metaverse-based surgical simulation with extended reality helps localize vessels during EC-IC bypass for moyamoya disease or chronic cerebral ischemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.